Subscribe
MENU
Home
BPCIA Litigations
PTAB Tracker
Appeals
FDA Approvals
Editors
Big Molecule Watch
All Brand Names
Abasaglar
Acellbia
Actemra
Adaly
Admelog
Alprolix
Amgevita
Amjevita
Avastin
Basaglar
Bavacirel
Benepali
Bengaluru
Bevacirel
Bevatas
Biceltis
Binocrit
Blincyto
Botox
Brenzys
CANMAb
Cimzia
Cizumab
Cyltezo
Dupixent
Elaprase
Enbrel
Entyvio
Epogen
Erbitux
Erelzi
Evenity
Eylea
Flixabi
Forteo
Fulphila
Glargia
Granix
Grastofil
Halimatoz
Hefiya
Herceptin
Herclon
Hertraz
Herzuma
Hulio
Humalog
Humira
Hyrimoz
Iclusig
Idelvion
Imraldi
Inflectra
Invictan
Ixifi
Kanjinti
Keytruda
Krabeva
Lamictal
Lantus
Lapelga
Lovenox
Lucentis
Lusduna
MabThera
Mabura
Movymia
Mvasi
Neulasta
Neupogen
Nexvue
Nivestym
Nucynta
Nucynta ER
Ocrevus
Ogivri
Oncaspar
Ontruzant
Opdivo
Orencia
Pelgraz
Pelmeg
Perjeta
Praluent
Procrit
Pulmozyme
regeneron
Remicade
Remsima
Renflexis
Repatha
Restasis
Retacrit
Rituxan
Rixathon
RoActemra
Samfenet
Semglee
Simponi
Soliris
SoloSTAR
Stelara
Suliqua
Taltz
Tecentriq
Terrosa
Toujou
Trazimera
Truxima
Tysabri
Udenyca
Usmal
Vascepa
Voltaire
Vyvanse
Xgeva
XLucane
Xolair
Xyrem
Zarxio
Zedora
Zioxtenzo
All Scientific Names
abatacept
ABP 501
adalimumab
aflibercept
alirocumab
atezolizumab
bevacizumab
BI 655066
blinatumomab
bococizumab
brigatinib
brodalumab
certoizumab pegol
certolizumab pegol
cetuximab
CT-P13
denosumab
dornase alfa
dupilumab
eculizumab
emicizumab
enoxaparin sodium
epoetin alfa
etanercept
evolucumab
fasinumab
filgrastim
fremanezumab
GHB
golimumab
guselkumab
icosapent ethyl
idursulfase
infliximab
infliximab-dyyb
insulin glargine
LBEC0101
lixisenatide
natalizumab
nivolumab
ocrelizumab
omalizumab
onabotulinumtoxinA
pegaspargase
pegfilgrastim
pembrolizumab
pertuzuzmab
ponatinib
prabotulinumtoxinA
ranibizumab
razumab
rituximab
romosuzumab
Sintilimab
taxane
teriparatide
tocilizumab
toclizumab
tralokinumab
trastuzumab
upadacitinib
ustekinumab
vedolizumab
All Company Names
AbbVie
Abzena
Academy of Managed Care Pharmacy (AMCP)
Accord Healthcare
ACON Investments
Acorda Therapeutics
Actavis
Adello Biologics
Alexion Pharmaceuticals
Allergan
Alliance for Safe Biologic Medicines
Alteogen
Alvogen
Alvotech
Amarin
America’s Health Insurance Plans (AHIP)
Amgen
Amneal
Amphastar
Apotex
Aprogen Biologics
Aragen Bioscience
Archigen Biotech
ARIAD Pharmaceuticals
Ariosa
Arsia Therapeutics
Arven Pharmaceuticals
Association for Accessible Medicines (AAM)
AstraZeneca
Aurobindo Pharma
Axis Biotec
AYUMI Pharmaceutical
Bavarian Nordic
Baxalta
Bio-Thera Solutions
Biocad
BioCND
Biocon
bioeq
Biogen
Biomarin
Biosidus
Biosimilar Medicines Group
Biosimilars Council
Biosimilars Forum
Biotechnology Innovation Organization (BIO)
Biovertiv
BlueCross BlueShield (BCBS)
Boehringer Ingelheim
Brazilian Society of Clinical Oncology
Bristol-Myers Squibb (BMS)
Catalent Pharma
Celgene
Celltrion
Chugai Pharmaceutical
Cinfa Biotech
Cipla
Clover Biopharmaceuticals
Coalition for Affordable Drugs
Coherus
CR Pharma
CSL
Cuozzo Speed Technologies
CVS
Daewoong
Daiichi Sankyo
DepoMed
Dr. Reddy’s
Eagle Pharmaceuticals
Elan Pharmaceuticals
Eli Lilly
Enzo Biochem
Epirus Biopharmaceuticals
Evolus
Formycon
Fresenius Kabi
Fuji Pharma
Fujifilm Kyowa Kirin Biologics (FKB)
GC Pharma
GE Healthcare
Gedeon Richter
Genentech
Generic Pharmaceutical Association (GPhA)
Genzyme
George Steuart Health
GlaxoSmithKline (GSK)
Glenmark Pharmaceuticals
Handok Pharmaceutical
Hetero Drugs
Hikma Pharmaceuticals
Hoffmann-La Roche
Hospira
Humus Capital Partners
Hyclone
Immunex
Impax
Innovent Biologics
Intas
International Generic and Biosimilar medicines Association (IGBA)
Italian Medicines Agency
Janssen
Jazz
JHL Biotech
Johnson & Johnson (J&J)
King Drug Company of Florence
Kyowa Hakko Kirin
Laboratorios PiSA
LEO Pharma
LG Chem
LG Life Sciences
Lupin
Mabion
MabTech
mAbxience
Mayo
Merck
Miraca Life Sciences
Mitsubishi Tanabe
Mochida Pharmaceutical
Momenta
Mundipharma
Mylan
NeuClone
Nichi-Iko
Nippon Kayaku
Novartis
nXn Partners
Oncobiologics
Ono Pharmaceuticals
Orion
Otsuka
Par
Pfenex
Pfizer
Pharmaceutical Care Management Association (PCMA)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmacyclics
PlantForm
Prestige BioPharma
Prometheus
Qilu Pharmaceutical
Regeneron
Reliance Life Sciences
Revance
Roche
Roxane
Sagent
Samsung Bioepis
Samsung Biologics
Sandoz
Sanofi
Sequenom
Shire
Simcere
SmithKline Beecham
Sonnet BioTherapeutics
Sorrento Therapeutics
St. Regis Mohawk
STADA
Swiss Pharma International AG
Takeda Pharmaceutical
Tanvex BioPharma
Teva Pharmaceuticals
Theradiag
TL Biopharmaceutical
Transposagen Biopharmaceuticals
TRPharm
UGA Biopharma
Valeant Pharmaceuticals
Valerius Biopharma AG
Vifor Pharma
World Health Organization (WHO)
XBrane Biopharma
YL Biologics
Yoshindo
Zydus Cadila
All Litigation
AbbVie v. Amgen (adalimumab)
AbbVie v. BI (adalimumab)
AbbVie v. Sandoz (adalimumab)
Amgen v. Adello (filgrastim)
Amgen v. Apotex (pegfilgrastim; filgrastim)
Amgen v. Coherus (pegfilgrastim)
Amgen v. Hospira (epoetin alfa)
Amgen v. Hospira (filgrastim)
Amgen v. Mylan (pegfilgrastim)
Amgen v. Sandoz (filgrastim; pegfilgrastim)
Amgen v. Sanofi (Praluent/alirocumab)
Genentech v. Amgen (bevacizumab)
Genentech v. Amgen (trastuzumab)
Genentech v. Celltrion (rituximab)
Genentech v. Celltrion (trastuzumab)
Genentech v. JHL (trade secret)
Genentech v. Pfizer (trastuzumab)
Genentech v. Samsung Bioepis (trastuzumab)
Genentech v. Sandoz (rituximab)
Immunex v. Sandoz (etanercept)
Immunex v. Sanofi (Dupixent/dupilumab)
Janssen v. Celltrion (infliximab)
Janssen v. Samsung Bioepis (infliximab)
momenta
Momenta v. Amphastar (enoxaparin)
Pfizer v. J&J (antitrust)
Sanofi v. Merck (insulin glargine)
Sanofi v. Mylan (insulin glargine)
Amgen v. Sandoz – D.N.J.
Amgen Complaint
